Search research articles
Contact Us
Filters
Showing results (31-40 of 55) with videos related to
Page
of 6
Sort By:
British Journal of Haematology
|
July 4, 2023
Clinico-biological features, treatment and prognosis of primary myeloid sarcoma: A French retrospective multi-centric observational study
Maya Belhadj, Barbara Burroni, Olivier Kosmider, et al.
Medicine
|
November 8, 2014
Sarcoidosis occurring after lymphoma: report of 14 patients and review of the literature
Jonathan London, Aurélie Grados, Christophe Fermé, et al.
Haematologica
|
February 24, 2018
Efficacy and safety of high-dose etoposide cytarabine as consolidation following rituximab methotrexate temozolomide induction in newly diagnosed primary central nervous system lymphoma in immunocompetent patients
Rudy Birsen, Lise Willems, Johan Pallud, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
August 28, 2025
Follicular helper T-cell lymphomas with EBV-positive neoplastic cells: a rare scenario with diagnostic implications
Barbara Burroni, Claire Lamaison, Elsa Poullot, et al.
Haematologica
|
July 14, 2022
Histological and genetic characterization and follow-up of 130 patients with chronic triple-negative thrombocytosis
Sandrine Lemoine, Clelia Mornet, Isabelle Quintin-Roue, et al.
Hematological Oncology
|
May 31, 2020
Whole genome copy number analysis in search of new prognostic biomarkers in first line treatment of mantle cell lymphoma. A study by the LYSA group
Yannick Le Bris, Florence Magrangeas, Anne Moreau, et al.
Blood
|
April 26, 2024
Obinutuzumab vs rituximab for transplant-eligible patients with mantle cell lymphoma
Clémentine Sarkozy, Mary Callanan, Catherine Thieblemont, et al.
Blood
|
November 18, 2023
The phase 2 LYSA study of prednisone, vinblastine, doxorubicin, and bendamustine for untreated Hodgkin lymphoma in older patients
Hervé Ghesquières, Daphné Krzisch, Emmanuelle Nicolas-Virelizier, et al.
Journal of Translational Medicine
|
November 6, 2019
The tumor inflammation signature (TIS) is associated with anti-PD-1 treatment benefit in the CERTIM pan-cancer cohort
Diane Damotte, Sarah Warren, Jennifer Arrondeau, et al.
Oncotarget
|
April 24, 2018
Prognostic value of early 18F-FDG PET scanning evaluation in immunocompetent primary CNS lymphoma patients
Rudy Birsen, Estelle Blanc, Lise Willems, et al.
Page
of 6
Search research articles
Search
Showing results (31-40 of 55) with videos related to
Sort By:
Page
of 6
British Journal of Haematology
|
July 4, 2023
Clinico-biological features, treatment and prognosis of primary myeloid sarcoma: A French retrospective multi-centric observational study
Maya Belhadj, Barbara Burroni, Olivier Kosmider, et al.
Medicine
|
November 8, 2014
Sarcoidosis occurring after lymphoma: report of 14 patients and review of the literature
Jonathan London, Aurélie Grados, Christophe Fermé, et al.
Haematologica
|
February 24, 2018
Efficacy and safety of high-dose etoposide cytarabine as consolidation following rituximab methotrexate temozolomide induction in newly diagnosed primary central nervous system lymphoma in immunocompetent patients
Rudy Birsen, Lise Willems, Johan Pallud, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
August 28, 2025
Follicular helper T-cell lymphomas with EBV-positive neoplastic cells: a rare scenario with diagnostic implications
Barbara Burroni, Claire Lamaison, Elsa Poullot, et al.
Haematologica
|
July 14, 2022
Histological and genetic characterization and follow-up of 130 patients with chronic triple-negative thrombocytosis
Sandrine Lemoine, Clelia Mornet, Isabelle Quintin-Roue, et al.
Hematological Oncology
|
May 31, 2020
Whole genome copy number analysis in search of new prognostic biomarkers in first line treatment of mantle cell lymphoma. A study by the LYSA group
Yannick Le Bris, Florence Magrangeas, Anne Moreau, et al.
Blood
|
April 26, 2024
Obinutuzumab vs rituximab for transplant-eligible patients with mantle cell lymphoma
Clémentine Sarkozy, Mary Callanan, Catherine Thieblemont, et al.
Blood
|
November 18, 2023
The phase 2 LYSA study of prednisone, vinblastine, doxorubicin, and bendamustine for untreated Hodgkin lymphoma in older patients
Hervé Ghesquières, Daphné Krzisch, Emmanuelle Nicolas-Virelizier, et al.
Journal of Translational Medicine
|
November 6, 2019
The tumor inflammation signature (TIS) is associated with anti-PD-1 treatment benefit in the CERTIM pan-cancer cohort
Diane Damotte, Sarah Warren, Jennifer Arrondeau, et al.
Oncotarget
|
April 24, 2018
Prognostic value of early 18F-FDG PET scanning evaluation in immunocompetent primary CNS lymphoma patients
Rudy Birsen, Estelle Blanc, Lise Willems, et al.
Page
of 6